Janneke Kohlen

Bird & Bird (The Hague)
Lawyer (Associate)

Janneke is a partner in Bird & Bird’s Competition & EU Law Group in The Hague where she specialises in competition law and public procurement law, advising on contentious and non-contentious matters for a broad variety of the firm’s clients with a specific focus on the Life Sciences sector as well as ICT and transportation. Janneke joined Bird & Bird in 2009 and was promoted to partner in May 2017. With in-depth experience in merger control, cartel cases and abuse of dominance issues, Janneke also has broad expertise in acting as a compliance officer in meetings with competitors. In addition, Janneke’s practice also consists of advising on distribution agreements and she frequently provides in-house competition compliance programmes and trainings to clients. This comes along with extensive experience in drafting codes of conducts for companies, with a focus on competition law. In addition, she advises a variety of Bird & Bird’s clients on issues throughout the public procurement process, from reviewing tender documents and advising clients on the questions to ask procuring entities, to representing companies in court. Distinctions: Ranked as an Up and Coming lawyer in category Competition/European Law. Chambers Europe, 2019. Janneke Kohlen is regarded as a "very talented" up-and-comer in the competition area. She has a specific focus on public procurement matters and advised Kinly as a third party in EUR82 million public procurement proceedings between the Dutch Police and Avex, the losing tenderer. Chambers Europe, 2019. Ranked as a Next Generation Partner in category EU and Competition.

Linked authors

Bird & Bird (The Hague)
Bird & Bird (The Hague)

Articles

172 Bulletin

Mariska Van De Sanden, Janneke Kohlen, Pauline Kuipers The Dutch Competition Authority publishes a sector report on the impact of biosimilars on competition between TNF-alfa inhibitors

171

Dutch competition authority ACM publishes a sector report on the impact of biosimilars on competition between TNF-alfa inhibitors* The Dutch competition authority, ACM, initiated a market study in 2018 into the effect of the introduction of biosimilars on the competition between TNF alfa (...)

Send a message